Error loading player: No playable sources found

230

Update on Immunotherapy for Renal Cell Carcinoma

Date
March 4, 2023
Credits
1 CH | 0.75 Rx | Expired March 5, 2025
$40
Standard Price

Learn more about immunotherapy and the role it plays in treating renal cell carcinoma.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/5/25.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

Diane Newman, DNP, CRNP, FAAN, BCB-PMD - Advisory Board for EBT Medical, Coloplast, and ConvaTec; conducts research for Hollister; editor for Digital Science Press

There are no other Planning Committee disclosures to declare.

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will be able to review the current frontline immune checkpoint treatments of metastatic RCC disease, discuss the results of triplet therapy, and review the impact of immune peri-operative therapy trials on the current frontline treatments.

Speaker

Speaker Image for Naomi Haas
The University of Pennsylvania

Related Products

Thumbnail for Transgender Health and Gender Affirming Surgery: Nursing Considerations
Transgender Health and Gender Affirming Surgery: Nursing Considerations
This presentation reviews transgender health and how to provide gender affirming care. We also discuss gender affirming surgery and nursing care and considerations…
Thumbnail for Neurogenic Bladder & Bowel: An Overview in Etiology, Diagnosis, and Treatment from Gestation to Gerontology
Neurogenic Bladder & Bowel: An Overview in Etiology, Diagnosis, and Treatment from Gestation to Gerontology
Neurogenic bladder and neurogenic bowel occur in patients who have congenital anomalies, tumors of the CNS, spinal cord injuries, stroke, and diseases of the CNS…
Thumbnail for Interstitial Cystitis: Understanding Bladder Pain Syndrome
Interstitial Cystitis: Understanding Bladder Pain Syndrome
The purpose of this presentation is to provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS), including discussion of treatments that should and should not be offered in the office setting by the advanced practice nurse…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.